JPMORGAN CHASE & CO - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$88,866
-30.7%
11,833
-18.6%
0.00%
Q2 2023$128,317
+12731.7%
14,532
+20660.0%
0.00%
Q1 2023$1,000
+99900.0%
700.0%0.00%
Q4 2022$1
-99.9%
700.0%0.00%
Q3 2022$1,000
-98.6%
70
-99.1%
0.00%
Q2 2022$69,000
-24.2%
7,735
-52.7%
0.00%
Q1 2022$91,00016,366
+23280.0%
0.00%
Q4 2021$0
-100.0%
70
-99.7%
0.00%
Q2 2021$146,000
+2.8%
20,021
-12.6%
0.00%
Q1 2021$142,000
+97.2%
22,914
+137.0%
0.00%
Q4 2020$72,000
+50.0%
9,670
+21.3%
0.00%
Q3 2020$48,000
-21.3%
7,971
+9.7%
0.00%
Q2 2020$61,000
+6000.0%
7,265
+6504.5%
0.00%
Q3 2019$1,000
-92.9%
110
-96.1%
0.00%
Q1 2019$14,000
-39.1%
2,831
-22.1%
0.00%
Q4 2018$23,000
+4.5%
3,633
+35.2%
0.00%
Q3 2018$22,000
-94.5%
2,687
-93.0%
0.00%
Q2 2018$398,00038,1360.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders